Clinical trials: Efficacy of PEGASUS
Gastric Cancer
To Evaluate Efficacy of Ursodeoxycholic Acid (UDCA) for the Prevention of Gallstone Formation After Gasterectomy
Of those patients who participated in PEGASUS-D FAS clinical trial, patient must sign the informed consent form in order to participate in this extension study.
- Trial name
- NCT05410535
- Testing
- Patients who continued UDCA 300mg medication, Patients who discontinued UDCA 300mg prescription
- Where
- South Korea
- Volunteers
- 431 people
- Sponsor
- Daewoong Pharmaceutical Co. LTD.
Intracranial Aneurysm
To Evaluate the Safety and Efficacy of Intracranial Stent Assisted Endovascular Treatment of Intracranial Aneurysms
The purpose of this study is to assess safety and effectiveness of the pEGASUS stent system.
- Trial name
- NCT06158087
- Testing
- pEGASUS Stent System
- Where
- China
- Volunteers
- 130 people
- Sponsor
- Shanghai Wallaby Medical Technologies Co.,Inc.
Trisomy 21, Trisomy 18
Study of the Efficacy of New Non-invasive Prenatal Tests for Screening for Fetal Trisomies Using Maternal Blood
Each year, 450,000 Canadian women become pregnant and, as a result of their participation in prenatal screening for Down syndrome, approximately 10,000 of them will have an amniocentesis (i.e.
- Conditions
- Trisomy 21, Trisomy 18, Trisomy 13
- Trial name
- PEGASUS (NCT01925742)
- Testing
- Integrated prenatal screening for Down's syndrome, Serum QUAD Assay for aneuploidy screening, Semiconductor MPSS NIPT assay using ccfDNA in maternal blood
- Where
- 5 sites in Canada
- Volunteers
- 3,819 people, healthy volunteers welcome
- Sponsor
- CHU de Quebec-Universite Laval
Efficacy of PEGASUS
Evaluating PEGASUS - a Group Intervention for Young People With an Autism Spectrum Disorder
When a clinician gives an autism spectrum disorder (ASD) diagnosis they hope this will be helpful to the person receiving it and their family.
- Trial name
- NCT01187940
- Testing
- PEGASUS
- Where
- United Kingdom
- Volunteers
- 40 people
- Sponsor
- Institute of Child Health